Gilead Sciences' data on two novel, once-yearly formulations of lenacapavir for PrEP support the further development of the ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

Josh Brown, CEO of Ritholtz Wealth Management, said during a program on CNBC last month that he’s paying attention to Gilead Sciences Inc (NASDAQ:GILD).

Tangney, a Master of Science in Public Health student at the Johns Hopkins Bloomberg School of Public Health in the Department of International Health’s Health Systems Program, was raised by a single ...

As Time Goes By,' currently playing on Christopher Street, is a new play about modern gay male loneliness starring two Jewish characters.

Studies find that patients actually see their pharmacists more frequently than their doctors; find out how much this critical ...

The six-time Grammy Award winner is as outspoken as she is talented, and she has never shied away from serious issues—like the AIDS epidemic, as she played a crucial role in bringing much-needed ...

Phase 1 Data Indicate Potential for Use of Once-Yearly Lenacapavir for HIV Prevention, with Plans to Launch a Phase 3 Trial in 2H 2025 – ...

MEDINA, Misamis Oriental (PIA) — Philippine Health Insurance Corporation (PhilHealth)-10 Regional Vice President Delio Aseron ...

Black artists in comics, Mucha-inspired pop-up tattoo, and an ode to Essex Hemphill: the upcoming exhibitions opening in D.C.

Oakland Dental Care is excited to announce that Dr. James P. Sara has officially joined the practice. Bringing a wealth of expertise and a passion for exceptional dental care, Dr. Sara is a valuable ...

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will find new ways to evade the human immune system.